Managing Director, Founder

Doug has dedicated his entire career to the life sciences and is passionate about making healthcare better. He has acted as an executive consultant for numerous Biotech, Pharma, and MedTech companies that continue to positively impact and revolutionize the way that we think about healthcare.

As the Principal and Founder of Renegade BioConsulting, Doug has  guided various US-based startups in the realm of fundraising, preparation for the public markets, and successful exits. He has also helped numerous startups from Europe and Asia successfully enter the US market.

Doug is a native Floridian, where he resides with his fiancé, Chelsea, along with their two dogs - Pippin and Gus. On top of science, he is also passionate about music and plays guitar, bass, keyboard, and drums.

Education: 

M.S., Biotechnology - Georgetown University 

B.S., Biological Sciences - Florida State University

Associate

Liam has had an unwavering passion for science and healthcare from a young age. In more recent years, he has become increasingly interested in science and biotechnology commercialization from universities. While completing his PhD and MA at Duke University, he has served as student consultant as a member of Duke’s Advanced Degree Consulting Club working closely with venture capital firms in the Raleigh-Durham area and a mentor to underrepresented students earning their PhD.  

He has also served as a Venture Fellow for Brazen Capital, a biotech venture capital fund focused on promoting Scientist-CEOs. During his time at Brazen, Liam has focused on portfolio development, investment due diligence, and capital raising for the fund. 

Liam’s thesis work at Duke aims to understand the contribution of mitochondrial dysfunction to Retinal Ganglion Cell degeneration in Optic Neuropathies. 

Analyst

Cissy is an Analyst at Intelligence Ventures. She also is actively involved with the American Red Cross, where she is 1 of 13 council members appointed to nationally represent and serve 100,000+ youth volunteers. 

She is also an Analyst at Startery, a one-stop-shop for startups and students to solve complex problems and build the future. Cissy is also a healthcare investment analyst at Wharton Asia Exchange.

Education

BS Economics, The Wharton School at University of Pennsylvania (in progress)

Analyst

George is an ambitious and dedicated professional, receiving his Doctor of Pharmacy degree from Virginia Commonwealth University in 2022. He currently serves as a Regulatory Affairs Fellow at Sumitomo Pharma America, Inc., where he is involved in all aspects of regulatory affairs and the drug development process.

His clinical expertise as a pharmacist, combined with his notable experience in drug development, equips him with a unique skillset to evaluate prospective portfolio companies. George’s keen interest in the biotechnology venture capital sector reflects his eagerness to contribute significantly to Intelligence Ventures and the ever-evolving world of artificial intelligence and the biotechnology industry.

Education:

PharmD - VCU School of Pharmacy

BS, Chemistry- Virginia Commonwealth University

AI and Healthcare Specialist

Ioanna has worked diligently towards reinforcing and expanding implementation of advanced computer science capabilities in biological sciences. Her contributions span from cell biology to Markov chain Boolean networks. She has been exceptionally productive during her academic journey, as evidenced by her authoring 12 articles and advancing in her doctoral training in Paris.

She was selected to participate in the McKinsey, ‘Next Generation Women Leaders’ workshop of 2023 and she has presented in numerous global science symposia. In addition, Ioanna is amongst the mentors at ‘Women On Top’, devoted to inspiring young female entrepreneurs in Greece.

As an AI and Healthcare Specialist Ioanna is responsible for connecting with our community on interesting topics related to our venture’s interests.

Education

BA, Bioinformatics and Biomathematics – Mount Holyoke College

Steven M. Gottlieb, M.D. stands as a prominent figure in the healthcare sector with over 30 years of leadership experience as a physician executive and serial entrepreneur. He specialized in anesthesiology, pain management, and critical care medicine at The Johns Hopkins Hospital. Dr. Gottlieb has a remarkable track record of founding and steering several healthcare companies to success.

Notably, he served as co-founder, CEO, and President of Anesthetix Management, a significant player in offering anesthesiology and pain management solutions across the US. Under his leadership, the company witnessed substantial growth, attracting investment from Summit Partners, eventually being acquired by TeamHealth, and making its way to an IPO. Following this, he became the CEO of TeamHealth Anesthesia, spearheading a division of one of the largest physician staffing solution providers in the US. Dr. Gottlieb has served on various boards and in leadership positions in hospital, community, corporate and professional organizations, including Medical Center Boards of Trustees, Boards of Health, and Physician Associations. Presently, he chairs several boards including J10x, an organization that serves as a strategic ally to entrepreneurial firms, fostering their growth and success.

Lee Metz is a seasoned business development and investor relations professional, boasting nearly two decades of experience in marketing alternative investment strategies across various domains including credit, equity, and private capital. Recently, she served as the Head of Investor Relations and Business Development at Livello Capital, a nascent distressed credit hedge fund established in 2020.

Before joining Livello, Ms. Metz held pivotal roles as the Head of Business Development for ACRE, a firm in the real estate private debt and equity sector, and a Managing Director at EJF Capital, focusing on marketing and investor relations, and steering the firm's private credit strategy in litigation finance. Her extensive career also includes notable positions at Collins Capital Investments and Merrill Lynch.

Ms. Metz initiated her career at Donaldson Lufkin and Jenrette's online division, now E*Trade, and holds a B.A., cum laude, in Economics from Vanderbilt University and an M.B.A. from Georgia State University's Robinson College of Business.

Ryan Johnson is an associate in the Technology and Life Sciences group at Goodwin. He represents emerging growth technology and life sciences companies, as well as venture capital funds. Ryan advises clients at every stage of their corporate lifecycle, including formation, corporate governance and securities law matters, venture capital financings, mergers and acquisitions and IPOs.

Ryan is licensed to practice law in New York.